Lanreotide Impurity 4 is a structurally related analogue generated during lanreotide synthesis or degradation. Subtle modifications influence disulfide topology, side-chain orientation, and chromatographic retention. Researchers use it as a reference standard for impurity profiling and stability assessment. Applications include process characterization, QC method validation, and peptide-variant structural comparison.
CAT No: Z10-101-226
Synonyms/Alias:(4R,7S,10S,13R,16S,19R)-13-((1H-Indol-3-yl)methyl)-19-((R)-2-amino-3-(naphthalen-2-yl)propanamido)-10-(4-aminobutyl)-16-(4-hydroxybenzyl)-7-isopropyl-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxylic acid
Lanreotide impurity 4 is a specialized carbohydrate-related compound that plays a significant role in the analytical and research landscape of peptide-based pharmaceuticals. As an identified process-related impurity associated with the synthesis of lanreotide, this compound is crucial for comprehensive quality assessment and method development within pharmaceutical research and manufacturing environments. Its presence, structure, and behavior offer valuable insights into the synthetic pathways, degradation mechanisms, and overall stability of peptide therapeutics. Lanreotide impurity 4 is typically characterized by advanced analytical techniques, making it instrumental for laboratories focused on the detailed study of peptide impurities and their impact on final drug products.
Pharmaceutical research: Lanreotide impurity 4 is extensively utilized in pharmaceutical research to investigate the formation and identification of process-related impurities in peptide drug synthesis. By incorporating this impurity into analytical studies, researchers can better understand the pathways through which unwanted by-products arise during the manufacturing process. This knowledge enables the optimization of synthetic protocols and purification methods, ultimately leading to improved yields and higher-quality peptide therapeutics. The presence of such impurities, when studied systematically, also provides a foundation for developing strategies to minimize their occurrence, thereby enhancing the overall safety and efficacy profile of the final pharmaceutical product.
Analytical method development: The use of lanreotide impurity 4 is critical in the development and validation of robust analytical methods, such as high-performance liquid chromatography (HPLC) and mass spectrometry (MS), for the detection and quantification of impurities in peptide formulations. By serving as a reference standard, this impurity allows scientists to calibrate their instruments and establish detection limits, ensuring accurate and reliable analysis of pharmaceutical samples. The availability of well-characterized impurities also supports the creation of impurity profiles, which are essential for monitoring the consistency and quality of peptide drug batches over time.
Stability studies: Lanreotide impurity 4 plays an important role in stability studies of peptide-based pharmaceuticals. By intentionally introducing this impurity into stability testing protocols, researchers can evaluate how environmental factors such as temperature, humidity, and light exposure influence the degradation of lanreotide and related compounds. These studies help to elucidate the mechanisms by which impurities are formed during storage and handling, providing valuable data for the design of improved packaging, storage conditions, and shelf-life predictions for peptide drugs.
Synthetic process optimization: The identification and quantification of lanreotide impurity 4 are integral to the optimization of peptide synthesis and purification processes. By monitoring the levels of this impurity at various stages of production, process chemists can pinpoint critical steps where by-product formation is most pronounced. This information guides the adjustment of reaction conditions, reagent selection, and purification techniques to minimize impurity generation, thereby increasing the efficiency and cost-effectiveness of peptide manufacturing.
Peptide impurity profiling: In the broader context of peptide impurity profiling, lanreotide impurity 4 serves as a model compound for the systematic study of related impurities across different peptide drugs. Its structural characteristics and formation pathways provide a basis for comparison with other impurities, facilitating the development of generalizable analytical strategies and impurity management protocols. By integrating this compound into impurity profiling workflows, researchers can build comprehensive impurity databases that support the ongoing advancement of peptide drug development and quality assurance.
In summary, lanreotide impurity 4 is an indispensable tool for a wide range of scientific applications, including pharmaceutical research, analytical method development, stability studies, synthetic process optimization, and peptide impurity profiling. Its unique properties and relevance to the peptide synthesis process make it a valuable resource for researchers and manufacturers seeking to enhance the quality, reliability, and scientific understanding of peptide-based pharmaceuticals. Through its use in these diverse applications, lanreotide impurity 4 contributes to the continuous improvement of analytical practices and the advancement of peptide chemistry research.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More